CELSION (NASDAQ:CLSN)
3.03
0.02 (0.66%)
| CELSION (NASDAQ:CLSN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $5.25 | ||
| Open | $3.02 | 52 Week Low | $1.60 | ||
| Day High | $3.05 | P/E | N/A | ||
| Day Low | $3.01 | EPS | $-1.36 | ||
| Volume | 45,431 | ||||
| More CLSN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CLN | 3 | XRX | 2 |
| ASPM | 2 | COV | 2 |
| DRAM | 2 | FRP | 2 |
| GETI | 2 | GMTN | 2 |
| AKRX | 1 | CYD | 1 |
| HCKT | 1 | MIM | 1 |
Entities who have mentioned CLSN
- Trading Radar | View Related Stories »
- Needham & Co | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- UBS | View Related Stories »
- The Children's Investment Fund (TCI) | View Related Stories »
View All ReportsStreetInsider.com Reports on CLSN
- Needham & Co Initiates Coverage on Celsion Corporation (CLSN) with a Buy
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- China's SFDA Approves Celsion Corp.'s (CLSN) ThermoDox for Phase III HEAT Trial in China
- Unusual 11 Mid-Day Movers 9/28: TIV, ASPM, CNLG, GETI, GMTN Higher; FRP, CLSN, XRX, DRAM Lower
- Morning Movers 9/28: ASPM, GETI, GMTN, ISR, ACS, HLCS Higher; FRP, CLSN, XRX, DRAM Lower
View All Press ReleasesCompany Press Releases on CLSN
- Celsion Reports Third Quarter 2009 Financial Results and Business Update
- Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009
- Celsion and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
- Investigator Meetings Completed in Japan and China for Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
- Celsion's Global Phase III ThermoDox(R) Trial Expands to Malaysia and the Philippines
StreetInsider Reports on CLSN by Category
View All BlogsBlogs on CLSN
- Celsion Is Granted SFDA Approval for China Cancer Trial
- Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
View All FilingsSEC Filings on CLSN
- Form 4 Celsion CORP For: Nov 19 Filed by: Tardugno Michael H
- Form 10-Q Celsion CORP For: Sep 30
- Form 8-K Celsion CORP For: Nov 10
Comments on recent CLSN articles
Comments on CLSN
No comments are currently available.
on Nov 12, 2009
at 09:59 AM Celsion What is the rational of the upgrade. Their loss widens. No other news
Article: Needham & Co Initiates Coverage on Celsion Corporation (CLSN) with a Buy